The original data for the figures. حسب Masashi Okawa (8951294)

الموضوعات:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. حسب Masashi Okawa (8951294)

الموضوعات:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

Raw data underlying figures 1–7. حسب Alejandra Barrera-Rosales (21656278)

الموضوعات:

Participant characteristics. حسب Ronald Kusolo (13200268)

الموضوعات:

Uganda 2023 NCD risk factor STEPS survey data. حسب Ronald Kusolo (13200268)

الموضوعات:

Uganda 2014 NCD risk factor STEPS survey data. حسب Ronald Kusolo (13200268)

الموضوعات:

Breaking strength and ash contents in the tibia. حسب Miloš Skřivan (5122037)

الموضوعات:

Performance characteristics of broilers. حسب Miloš Skřivan (5122037)

الموضوعات:

Digesta viscosity and pH in the ileum. حسب Miloš Skřivan (5122037)

الموضوعات:

Nutrient retention in broilers (g/kg/day). حسب Miloš Skřivan (5122037)

الموضوعات:

Fatty acid composition (mg/100 g) of breast meat. حسب Miloš Skřivan (5122037)

الموضوعات:

Fat contents (g/kg) in breast meat and liver. حسب Miloš Skřivan (5122037)

الموضوعات:

Summary of previous work. حسب Junyan Wang (4738518)

الموضوعات:

Comparison of MAP@0.5 results from experiments. حسب Junyan Wang (4738518)

الموضوعات:

YOLO11. حسب Junyan Wang (4738518)

الموضوعات:

Structure of the SCI-YOLO11 network. حسب Junyan Wang (4738518)

الموضوعات:

Comparative experimental results. حسب Junyan Wang (4738518)

الموضوعات: